Dentists explore new research on the role of LISTERINE®
Antiseptic in reducing supragingival plaque
Drs. Marie Jackson, dentist and member of LISTERINE®’s Advisory Board, and Michael Lynch, Global Director of Oral Care Scientific Engagement at Johnson & Johnson Consumer, Inc., discuss details of published research demonstrating that LISTERINE® Antiseptic Mouthwash is 4.6x more effective in reducing supragingival plaque compared to flossing*. The research also offered more insights into the dental care habits, practices, and beliefs of dental subjects, including the importance of brushing, flossing, and rinsing as part of a daily routine.
*Flossing by a dental hygienist. Sustained supragingival plaque reduction after dental prophylaxis. Not a replacement for brushing or flossing.
The Science Behind the Success
There is extensive clinical evidence supporting the use of LISTERINE® products, including evidence of safety and efficacy, and technical innovations. This resource gives you access to head-to-head data and product data.
Explore more featured content on the Antiseptic
Product Learning Center sponsored by LISTERINE®, including:
- Understanding the Safety and Uses of Alcohol
- Flossing: Part of a Comprehensive Approach to Daily Oral Care
- Clearing Up the Myths about Antiseptic Mouthrinse—With Science